Beijing Chunlizhengda Medical Instruments Co Ltd Net Asset Quality Index
Beijing Chunlizhengda Medical Instruments Co Ltd net asset quality index. Beijing Chunlizhengda Medical Instruments Co Ltd (688236) has a Net Asset Quality Index of 84.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.54 Billion minus total liabilities of CN¥554.08 Million yields net assets of CN¥2.99 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 688236 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2024)
Net asset quality index of Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2024. This chart shows how Beijing Chunlizhengda Medical Instruments Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 84.3%, representing net assets of CN¥2.99 Billion against total assets of CN¥3.54 Billion CNY. See 688236 net assets for net asset value and shareholders' equity analysis.
Beijing Chunlizhengda Medical Instruments Co Ltd Net Asset Quality Index by Year (2012–2024)
Beijing Chunlizhengda Medical Instruments Co Ltd net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 688236 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 81.4% | CN¥2.82 Billion | CN¥3.47 Billion | CN¥644.39 Million | ▲ +2.5 pp |
| 2023 | 78.9% | CN¥2.88 Billion | CN¥3.65 Billion | CN¥770.33 Million | ▼ -0.9 pp |
| 2022 | 79.8% | CN¥2.72 Billion | CN¥3.41 Billion | CN¥690.07 Million | ▼ -2.5 pp |
| 2021 | 82.3% | CN¥2.47 Billion | CN¥3.00 Billion | CN¥530.58 Million | ▲ +12.2 pp |
| 2020 | 70.1% | CN¥1.08 Billion | CN¥1.54 Billion | CN¥460.41 Million | ▲ +3.4 pp |
| 2019 | 66.7% | CN¥806.59 Million | CN¥1.21 Billion | CN¥402.72 Million | ▼ -10.4 pp |
| 2018 | 77.1% | CN¥628.14 Million | CN¥814.74 Million | CN¥186.60 Million | ▼ -7.9 pp |
| 2017 | 85.0% | CN¥538.47 Million | CN¥633.66 Million | CN¥95.19 Million | ▼ -4.1 pp |
| 2016 | 89.0% | CN¥480.91 Million | CN¥540.13 Million | CN¥59.22 Million | ▲ +0.4 pp |
| 2015 | 88.6% | CN¥423.56 Million | CN¥478.04 Million | CN¥54.49 Million | ▲ +2.8 pp |
| 2014 | 85.9% | CN¥205.92 Million | CN¥239.86 Million | CN¥33.94 Million | ▼ -3.8 pp |
| 2013 | 89.7% | CN¥179.89 Million | CN¥200.63 Million | CN¥20.74 Million | ▼ -2.7 pp |
| 2012 | 92.4% | CN¥173.17 Million | CN¥187.51 Million | CN¥14.34 Million | — |